Penetrating Solution (QPS)
topical formulations of NSAIDs do not effectively penetrate the
barrier of the stratum corneum (outermost layer of skin). Hence,
they play a limited role in pain management. As a result, the medical
profession continues to depend on oral NSAIDs, which are known to
have severe side effects on the stomach, kidneys & cardiovascular
Technology enables an effective drug delivery of drugs through
the stratum corneum. QPS is an acronym for Quick Penetrating Solution.
It is a patented drug delivery platform which provides quick and
comprehensive penetration of the drug through the stratum corneum.
QPS Technology provides a unique base in which the drug is solubilised.
The base gets absorbed into the skin & thereby, carries the drug
through the barrier of the stratum corneum. QPS base is non-aqueous,
yet can be washed with water. Further the base is non-volatile,
non-irritant, an emollient & non-staining.
QPS is the world's first Transdermal preparation of diclofenac,
which provides excellent pain relief after topical application,
by enhancing the penetration of diclofenac through the skin. Dynapar
QPS is backed by proof of concept pharmacokinetic studies as well
as clinical trials. Since Dynapar QPS provides prompt pain relief
upon being administered to any inflamed area (knee, back, elbow,
neck, ankle, etc.), it minimises or eliminates the patient's requirement
of oral pain killers. Dynapar QPS, therefore, brings a paradigm
shift in the management of musculoskeletal pain.
technology enables us to manufacture many more topical formulations
where currently available formulations do not provide adequate clinical
benefits. Phlebotroy QPS is a novel topical heparin formulation,
which provides significantly enhanced penetration of heparin sodium
through the skin, resulting in faster resolution of superficial
thrombophlebitis as compared to conventional topical heparin creams
or ointments. QPS formulations of a few other drugs are under development.